
- Audums
- Saphenous vein
- Slimība
- Normal saphenous vein endothelium (primary cells; non-tumorigenic)
- Metastāžu vieta
- Not applicable (normal, non-tumorigenic primary cell)
- Sinonīmi
- HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121
Dokumenti
Cilvēka saphena vēnas endotēlija šūnas (HSVEC)
Primary cell · Preces numurs 300699
Venous endothelium for bypass graft research
Pielāgošana / Ieteikumi
- Cilvēka saphena vēnas endotēlija šūnas (HSVEC)Primary cell€1,220.00
01Vispārīga informācija
- Apraksts
Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.
HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.
- Audums
- Saphenous vein
- Slimība
- Normal saphenous vein endothelium (primary cells; non-tumorigenic)
- Metastāžu vieta
- Not applicable (normal, non-tumorigenic primary cell)
- Pieteikumi
- Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
- Sinonīmi
- HSaVEC
- HSVEC
- Human saphenous vein endothelial cells
- provitro 1210121
02Ziedotājs
- Donora vecums
- Lot-specific (see CoA)
- Etniskā piederība
- Lot-specific (see CoA)
03Klasifikācija
- Organisms
- Cilvēks
- Sekss
- Atkarībā no partijas
- Augšanas īpašības
- Atbalstītājs
- ĢMO statuss
- Bez ĢMO
- Sīkāka informācija par ĢMO statusu
- No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
- Bioloģiskās drošības līmenis
- 1
04Raksturlielumi
- Morfoloģija
- Cobblestone (endothelial)
- Šūnu tips
- Primary endothelial cells
- Tumorogēns
- No
- Laiks, kas nepieciešams, lai skaits dubultojās
- approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)
05Apstrāde un audzēšana
- Barotne
- Endothelial Cell Growth Medium
- Inkubācijas vide
37°C, 5% CO2, saturated humidity.
- Papildinājumi
- EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
- Disociācijas reaģents
- Subculture reagents as recommended on the certificate of analysis
- Kolbas pārklājums
- 0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
- Pārstādīšana
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
- Sadalījuma attiecība
- 1 to 3
- Sēšanas blīvums
- More than 6,000 cells/cm²
- Šķidruma atjaunošana
- 24 hours after seeding, then every 48 to 72 hours
- Atgūšanās pēc atkusņa
Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.
- Atkausēšana un kultivēšana
Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.
Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.
Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.
Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.
Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.
Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
Recommended seeding density: more than 6,000 cells/cm².
06Kvalitātes kontrole un kriokonservācija
- Sterilitāte
Mycoplasma contamination is excluded by PCR.
To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.
- Saldēšanas barotne
- As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
- Uzglabāšanas nosacījumi
For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.
- Piegādes nosacījumi
Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.
07Pazīmes un uzņēmība
- Virsmas antigēni
- CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
- Ekspresētie receptori
- VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)
08Identifikatori
- Atsauce
- Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
- NCBI nodokļu identifikācijas numurs
- 9606
- Cellosaurus
- Not assigned
09Juridiskie jautājumi un drošība
- Drošības pasākumi
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Primary cells are of human origin, and no known test procedure can ensure the complete absence of infectious agents. Handle all products as potentially infectious.
- Garantija
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Nepieciešams materiālu nodošanas līgums
- Jā